Kim Jean Jinsun 4
4 · Avidity Biosciences, Inc. · Filed Jan 11, 2021
Insider Transaction Report
Form 4
Kim Jean Jinsun
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-01-11+30,000→ 30,000 totalExercise: $27.63Exp: 2031-01-10→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The option was granted on January 11, 2021 and shall vest in substantially equal monthly installments over the three years following the grant date, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.